doi:10.3969/j.issn.1673-8640.2020.10.027

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 13

[1]	WEI M,YUAN J,LIU Y,et al.Novel coronavirus infection in hospitalized infants under 1 year of age in China[J]. JAMA,2020:323(13):1313-1314.
[2]	KAM K Q,YUNG C F,CUI L,et al.A well infant with coronavirus disease 2019(COVID-19) with high viral load[J]. Clin Infect Dis,2020,71(15):847-849.
[3]	ZHOU F,YU T,DU R,et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan,China:a retrospective cohort study[J]. Lancet,2020,395(10229):1054-1062.
[4]	CHEN W,LAN Y,YUAN X,et al.Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity[J]. Emerg Microbes Infect,2020,9(1):469-473.
[5]	ZHANG W,DU R H,LI B,et al.Molecular and serological investigation of 2019-nCoV infected patients:implication of multiple shedding routes[J]. Emerg Microbes Infect,2020,9(1):386-389.
[6]	YANG X,YU Y,XU J,et al.Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan,China:a single-centered,retrospective,observational study[J]. Lancet Respir Med,2020,8(4):e26.
[7]	ZHAO D,YAO F,WANG L,et al.A comparative study on the clinical features of coronavirus 2019(COVID-19) pneumonia with other pneumonias[J]. Clin Infect Dis,2020,71(15):756-761.
[8]	LI L Q,HUANG T,WANG Y Q,et al.COVID-19 patients' clinical characteristics,discharge rate and fatality rate of meta-analysis[J]. J Med Virol,2020,92(6):577-583.
[9]	LI A M,NG P C.Severe acute respiratory syndrome(SARS) in neonates and children[J]. Arch Dis Child Fetal Neonatal Ed,2005,90(6):F461-F465.
[10]	HON K L,LEUNG C W,CHENG W T,et al.Clinical presentations and outcome of severe acute respiratory syndrome in children[J]. Lancet,2003,361(9370):1701-1703.
[11]	BITNUN A,ALLEN U,HEURTER H,et al.Children hospitalized with severe acute respiratory syndrome-related illness in Toronto[J]. Pediatrics,2003,112(4):e261.
[12]	SHEN K,YANG Y,WANG T,et al.Diagnosis,treatment,and prevention of 2019 novel coronavirus infection in children:experts' consensus statement[J]. World J Pediatr,2020,16(3):223-231.
[13]	CHAN J F,YUAN S,KOK K H,et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission:a study of a family cluster[J]. Lancet,2020,395(10223):514-523.

时间	咽拭子样本		肛拭子样本		血清样本
时间	ORF基因CT值	N基因CT值	ORF基因CT值	N基因CT值	ORF基因CT值	N基因CT值
第1天	未检测到	未检测到
第3天	32.7	31.8
第13天	31	32	未检测到	未检测到	未检测到	未检测到
第16天	未检测到	未检测到	35.2	33.2
第19天	未检测到	38.4	36.8	32.4	未检测到	未检测到
第22天	未检测到	未检测到	36.8	36.8	未检测到	未检测到
第25天	未检测到	未检测到	未检测到	未检测到
第28天	未检测到	未检测到	未检测到	未检测到

时间	咽拭子样本		肛拭子样本		血清样本
时间	ORF基因CT值	N基因CT值	ORF基因CT值	N基因CT值	ORF基因CT值	N基因CT值
第1天	未检测到	未检测到
第3天	32.7	31.8
第13天	31	32	未检测到	未检测到	未检测到	未检测到
第16天	未检测到	未检测到	35.2	33.2
第19天	未检测到	38.4	36.8	32.4	未检测到	未检测到
第22天	未检测到	未检测到	36.8	36.8	未检测到	未检测到
第25天	未检测到	未检测到	未检测到	未检测到
第28天	未检测到	未检测到	未检测到	未检测到

日期	免疫层析法		胶体金法		酶联免疫法
日期	IgM	IgG	IgM	IgG	IgM	IgG
隔离第9天	+	+	+	+	0.293（+）	0.335（+）
隔离第15天	+	+	+	+	0.168（+）	0.411（+）
隔离第18天	-	+	-	+	0.061（-）	0.536（+）

日期	免疫层析法		胶体金法		酶联免疫法
日期	IgM	IgG	IgM	IgG	IgM	IgG
隔离第9天	+	+	+	+	0.293（+）	0.335（+）
隔离第15天	+	+	+	+	0.168（+）	0.411（+）
隔离第18天	-	+	-	+	0.061（-）	0.536（+）

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 13

Related Articles 15

Recommended Articles

Metrics